PMID: 9428680Jan 15, 1998Paper

Pharmacological concentrations of suramin inhibit the binding of alpha2-macroglobulin to its cell-surface receptor

European Journal of Biochemistry
G Vassiliou

Abstract

Suramin is a polysulfated drug used in the treatment of cancer and AIDS. High concentrations (1 mg/ml) of suramin did not affect the ability of native alpha2-macroglobulin (alpha2M) to inhibit proteinases nor did it prevent conversion of native alpha2M to the 'fast' receptor-binding form. Nevertheless, pharmacological concentrations (below 250 microg/ml) of suramin prevented the interaction between methylamine-activated alpha2M and its receptor, the low-density-lipoprotein-receptor-related protein. Inhibition was demonstrated at the molecular level and was not due to calcium sequestration by the drug, irreversible denaturation of the receptor, or a non-specific polyanion effect (since heparin and dextran sulfate did not alter the binding of alpha2M). The ability of suramin to accelerate the dissociation of pre-bound alpha2M was consistent with a non-competitive mechanism of inhibition although the possibility of a competitive component cannot be eliminated. I discuss how the inhibition of alpha2M-binding by suramin may contribute to the antiproliferative properties of this drug.

References

Dec 5, 1975·Biochimica Et Biophysica Acta·M T DebanneJ Dolovich
Jun 22, 1992·Biochimica Et Biophysica Acta·W JessupR T Dean
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A SteinC E Myers
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·I WarshawskyA L Schwartz
Sep 10, 1994·Annals of the New York Academy of Sciences·S L GoniasM A Hayes

❮ Previous
Next ❯

Citations

Apr 20, 2005·Biochemistry·Stefanos A TsiftsoglouRobert B Sim

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.